正文翻译排队
该来源正文已进入翻译队列，中文正文生成前先展示摘要和原始出处入口。
摘要
The U.S. Food and Drug Administration today issued a proposed rule that, if finalized, would create a streamlined registration pathway for distributed manufacturing establishments that operate as a single establishment using a “hub-and-spoke” model.
FDA Proposes Rule to Modernize Drug Manufacturing Registration
The U.S. Food and Drug Administration today issued a proposed rule that, if finalized, would create a streamlined registration pathway for distributed manufacturing establishments that operate as a single establishment using a “hub-and-spoke” model.